Skip to main content

NeoGenomics Raises $3M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NeoGenomics last week announced it raised $3 million.

Five members of the Ft. Myers, Fla.-based company's board and senior management as well as two existing institutional investors participated in the raise, which was priced at $1.50 per share. A total of 2 million shares of new common stock were issued by NeoGenomics.

No warrants were issued and no placement agent was used in the transaction, the company said. It plans to use proceeds to strengthen its financial position and fund growth initiatives, it said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.